Table of Contents

1 Industry Outlook 8
1.1 IVD Industry Structure and Overview 8
1.2 Major Market Factors and Growth Drivers 13
1.3 Total Addressable Market 15
1.4 Industry Trends 16
2 Report Outline 18
2.1 Report Scope 18
2.2 Report Summary 18
2.3 Research Methodology 19
2.4 Report Assumptions 21
3 Market Snapshot 22
3.1 Market Definition - Infoholic Research 22
3.2 Advantages of IVD 22
3.3 Importance of IVD 22
3.4 Segmented Addressable Market 22
3.5 Trends in the Indian In Vitro Diagnostics Market 23
3.6 Related Market 25
4 Market Outlook 26
4.1 Market Segmentation 26
4.2 PESTEL Analysis 27
4.3 Porter 5 (Five) Forces 28
5 Market Characteristics 29
5.1 DRO - Market Dynamics 29
5.1.1 Drivers 30
5.1.1.1 Economic growth, increasing population, urbanization, and rising healthcare expenditure per capita 30
5.1.1.2 Sedentary lifestyle, increasing prevalence of smoking and alcohol consumption resulting in incidence of lifestyle-related chronic disorders, cancer, and infectious diseases 30
5.1.1.3 Growing penetration of IVD testing in tier-II and III cities 31
5.1.1.4 Growing market of biomarker-based and genetic testing in India 31
5.1.2 Opportunities 31
5.1.2.1 Point-of-care testing, near patient testing, and home-based testing products and services (direct-to-patient testing services) 31
5.1.2.2 Adoption of fully automated systems in India and increasing number of phase-III clinical trials in India 31
5.1.3 Restraints 31
5.1.3.1 High costs of testing cancer, genetic disorders, and other disease 31
5.1.3.2 Tightening regulatory requirements but lack of reimbursement policies 32
5.1.4 DRO - Impact Analysis 34
5.1.5 Key Stakeholders 35
6 IVD Market Segments: Reagents and Equipment 36
7 Technology Types: Market Size and Analysis 37
7.1 Overview 37
7.2 Immunoassay 38
7.3 Biochemistry 39
7.4 Hematology 41
7.5 Microbiology 42
7.6 Blood Gas & Electrolytes 43
7.7 Molecular Diagnostics 45
7.8 Urinalysis 47
7.9 Coagulation 47
8 Applications: Market Size and Analysis 49
8.1 Overview 49
8.2 Oncology 49
8.3 Infectious Disease 49
8.4 Diabetes 49
8.5 Cardiology 49
8.6 Nephrology 50
8.7 Autoimmune Disease 50
8.8 Others 50
9 End-users: Market Size and Analysis 51
9.1 Overview 51
9.2 Hospitals 51
9.3 Laboratories 51
9.4 Home Care 51
9.5 Academic and Research Institutes 51
9.6 Others 51
10 Competitive Landscape 52
10.1 Overview 52
11 Vendors Profile 53
11.1 Abbott Laboratories 53
11.2 Danaher Corporation 55
11.3 bioMerieux 58
11.4 F. Hoffmann La Roche 61
11.5 Siemens 64
11.6 Transasia Bio-Medical Ltd 67
12 Companies to Watch for 70
12.1 Sysmex Corporation 70
12.2 Thermo Fisher Scientific 71
12.3 Bio-Rad Laboratories 72
12.4 Ortho Clinical Diagnostic 73
12.5 QIAGEN N.V 74
12.6 Shanghai Fosun Pharmaceutical Co. Ltd 75
Annexure 77
12.6.1 Abbreviations 77